All articles by Jangoulun Singsit

Jangoulun Singsit

Biocartis introduces new Idylla assay for gene fusion testing

Molecular diagnostics firm Biocartis has launched Idylla GeneFusion Assay as a rapid lab workflow solution for gene fusion testing.

BioVaxys and Inotiv to conduct preclinical toxicity studies for Covid-T

BioVaxys has signed an agreement with Bioanalytical Systems (Inotiv) to conduct preclinical toxicity studies for its Covid-T immunodiagnostic programme.

CureApp completes Phase III clinical trial of DTx app in Japan

CureApp has announced the completion of a Phase III clinical trial of its digital therapeutic app (DTx) in Japan to treat hypertension.

US FDA approves Boston Scientific’s TheraSphere technology to treat HCC

The US Food and Drug Administration (FDA) has granted approval to Boston Scientific’s TheraSphere Y-90 Glass Microspheres technology to treat patients with hepatocellular carcinoma (HCC).

Altasciences qualifies serological assay to detect IgG antibodies

Altasciences, in collaboration with the National Research Council of Canada (NRC), has qualified a quantitative serological assay to detect the presence of SARS-CoV-2 IgG antibodies.

FDA grants marketing authorisation to BioFire’s SARS-CoV-2 diagnostic test

The US Food and Drug Administration (FDA) has granted marketing authorisation to BioFire Diagnostics’ SARS-CoV-2 test.

GenScript and G42 Healthcare partner to explore solutions for Covid-19

GenScript Biotech’s subsidiary GenScript Biotech Singapore has signed an agreement with UAE’s G42 Healthcare for exploring new solutions to fight against Covid-19.

EUROIMMUN introduces automated microscope for advanced diagnostics

PerkinElmer’s subsidiary EUROIMMUN has introduced the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope with EUROLabOffice 4.0 (ELO 4.0) software for modern diagnostics.

University of Rhode Island develops new saliva-based Covid-19 test

Researchers at the University of Rhode Island (URI) in the US have developed a saliva-based test to detect the Covid-19 virus.

MicroPort sees increased adoption of Kinematic Alignment for knee system

MicroPort Orthopedics has announced that it witnessed increased adoption of its Kinematic Alignment (KA) approach for the Evolution Medial-Pivot knee system to improve patient outcomes.